Figure 4.

Flow Cytometric Analysis of crLV-Derived NIH45-46 CAR T Cells from HIV Donor

(A and B) CD4⁺ (A) and CD8⁺ (B) crLV- and LV- derived NIH45-46 CAR expression in HIV-donor T cells. (C) CD4⁺ and CD8⁺ percentage on day 7 in crLV- and LV-derived NIH45-46 CAR HIV-donor T cells. (D) Transduced T cells with crLV- or LV-derived NIH45-46 were co-cultured with GFP-expressing HEK.GP160s or HEKs for 24 h prior to analyzing CD137 expression by flow cytometry. This is a representative sample of technical replicates (n = 2).